A Multicenter, Randomized, Double-blind, Placebocontrolled, Phase 1b/2a Study of WVE-004 Administered Intrathecally to Patients with C9orf72- associated Amyotrophic Lateral Sclerosis (ALS) or Frontotemporal Dementia (FTD)

  • Rowe, Dominic (Primary Chief Investigator)
  • Gan, Richard (Research Coordinator)
  • Ordonez Artunduaga, Paula (Research Coordinator)

Project: Research

Project Details

Short titleWVE-004-001
StatusNot started